Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

706 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ergolide mediates anti-cancer effects on metastatic uveal melanoma cells and modulates their cellular and extracellular vesicle proteomes.
Sundaramurthi H, Tonelotto V, Wynne K, O'Connell F, O'Reilly E, Costa-Garcia M, Kovácsházi C, Kittel A, Marcone S, Blanco A, Pallinger E, Hambalkó S, Piulats Rodriguez JM, Ferdinandy P, O'Sullivan J, Matallanas D, Jensen LD, Giricz Z, Kennedy BN. Sundaramurthi H, et al. Open Res Eur. 2023 Nov 13;3:88. doi: 10.12688/openreseurope.15973.2. eCollection 2023. Open Res Eur. 2023. PMID: 37981907 Free PMC article.
1,4-dihydroxy quininib activates ferroptosis pathways in metastatic uveal melanoma and reveals a novel prognostic biomarker signature.
Tonelotto V, Costa-Garcia M, O'Reilly E, Smith KF, Slater K, Dillon ET, Pendino M, Higgins C, Sist P, Bosch R, Passamonti S, Piulats JM, Villanueva A, Tramer F, Vanella L, Carey M, Kennedy BN. Tonelotto V, et al. Cell Death Discov. 2024 Feb 10;10(1):70. doi: 10.1038/s41420-023-01773-8. Cell Death Discov. 2024. PMID: 38341410 Free PMC article.
Plant-derived cannabinoids as anticancer agents.
O'Reilly EM, Cosgrave JM, Gallagher WM, Perry AS. O'Reilly EM, et al. Trends Cancer. 2022 May;8(5):350-357. doi: 10.1016/j.trecan.2022.01.017. Epub 2022 Mar 5. Trends Cancer. 2022. PMID: 35260379
epiCaPture: A Urine DNA Methylation Test for Early Detection of Aggressive Prostate Cancer.
O'Reilly E, Tuzova AV, Walsh AL, Russell NM, O'Brien O, Kelly S, Dhomhnallain ON, DeBarra L, Dale CM, Brugman R, Clarke G, Schmidt O, O'Meachair S, Patil D, Pellegrini KL, Fleshner N, Garcia J, Zhao F, Finn S, Mills R, Hanna MY, Hurst R, McEvoy E, Gallagher WM, Manecksha RP, Cooper CS, Brewer DS, Bapat B, Sanda MG, Clark J, Perry AS. O'Reilly E, et al. JCO Precis Oncol. 2019;2019:PO.18.00134. doi: 10.1200/PO.18.00134. Epub 2019 Jan 14. JCO Precis Oncol. 2019. PMID: 30801051 Free PMC article.
A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer.
Zhao F, Olkhov-Mitsel E, Kamdar S, Jeyapala R, Garcia J, Hurst R, Hanna MY, Mills R, Tuzova AV, O'Reilly E, Kelly S, Cooper C; Movember Urine Biomarker Consortium; Brewer D, Perry AS, Clark J, Fleshner N, Bapat B. Zhao F, et al. Clin Epigenetics. 2018 Nov 23;10(1):147. doi: 10.1186/s13148-018-0575-z. Clin Epigenetics. 2018. PMID: 30470249 Free PMC article.
Adjuvant Cytotoxic Chemotherapy may not be Associated with a Survival Advantage for Resected Intrahepatic Cholangiocarcinoma.
Sharib J, Rhodin KE, Liu A, McIntyre S, Bartholomew A, Masoud S, DeLaura I, Kemeny NE, Cercek A, Harding JJ, O'Reilly EM, Abou-Alfa GK, Reidy-Lagunes D, Connell LC, Dika IE, Balachandran VP, Drebin J, Soares KC, Wei AC, Kingham TP, D'Angelica MI, Uronis H, Strickler J, Hsu SD, Morse M, Zani S, Allen PJ, Jarnagin WR, Lidsky ME. Sharib J, et al. Among authors: o reilly em. Ann Surg Oncol. 2025 Jan 18. doi: 10.1245/s10434-024-16799-0. Online ahead of print. Ann Surg Oncol. 2025. PMID: 39827317
Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival.
Varghese AM, Perry MA, Chou JF, Nandakumar S, Muldoon D, Erakky A, Zucker A, Fong C, Mehine M, Nguyen B, Basturk O, Balogun F, Kelsen DP, Brannon AR, Mandelker D, Vakiani E, Park W, Yu KH, Stadler ZK, Schattner MA, Jarnagin WR, Wei AC, Chakravarty D, Capanu M, Schultz N, Berger MF, Iacobuzio-Donahue CA, Bandlamudi C, O'Reilly EM. Varghese AM, et al. Among authors: o reilly em. Nat Med. 2025 Jan 3. doi: 10.1038/s41591-024-03362-3. Online ahead of print. Nat Med. 2025. PMID: 39753968
Impact of Financial Toxicity on Treatment Adherence and Quality of Life in Pancreatic Cancer.
Schleimer LE, Aviki E, Kalvin HL, Magnin J, Sokolowski SS, Kingham TP, O'Reilly EM, Varghese AM, Soares KC, Drebin J, D'Angelica MI, Jarnagin WR, Gonen M, Thom B, Wei AC. Schleimer LE, et al. Among authors: o reilly em. JCO Oncol Pract. 2024 Dec 20:OP2400528. doi: 10.1200/OP-24-00528. Online ahead of print. JCO Oncol Pract. 2024. PMID: 39705655
706 results